This website is for the U.S, for the other countries please refer to this link.
SUDOSCAN in autoimmune small fiber neuropathy Trevino, Jorge A. M.D., Novak, Peter MD. Ph.D. Article title: TS-HDS and FGFR3 Antibodies in Small Fiber Neuropathy and Dysautonomia. Muscle Nerve. 2021 Apr 1 In this study JA Trevino and P Novak from Brigham and Women’s Hospital, Harvard Medical School, Boston, tested small fiber neuropathy (SFN) in idiopathic …
Multidisciplinary French speaking day of Amyloidosis – JFMA 2020 Last month, SUDOSCAN was presented at the virtual Multidisciplinary French speaking day of Amyloidosis. The congress gathered 300 participants with a large scientific program on the different amyloidosis types. Amyloidosis is an acquired or hereditary rare disease due to amyloid protein deposits into organs. Several types …
SUDOSCAN in wild-type cardiac amyloidosis and AA amyloidosis – JFMA 2020 Read More »
SUDOSCAN COMBINED TO OTHER DIAGNOSIS TESTS TO CONFIRM SMALL FIBER NEUROPATHY V. Fabry, A. Gerdelat, B. Acket, P. Cintas, V. Rousseau, E. Uro-Coste, S. M. Evrard and A. Pavy-Le Traon. Article title: “Which Method for Diagnosing Small Fiber Neuropathy?” Front. Neurol., 05 May 2020. In a recent study conducted at Toulouse University Hospital, France, …
SUDOSCAN combined to other diagnosis tests to confirm small fiber neuropathy Read More »
Castro J, Miranda B, Castro I, de Carvalho M, Conceição I.
Sahuc P, Chiche L, Dussol B, Pouget J, Franques J.
Promotional Communication. The medical devices SUDOSCAN is cleared by the US Food and Drug Administration (FDA). The test allows screening and monitoring of peripheral autonomic neuropathies. It can be performed in diabetic patients or in patients suffering from neurological diseases involving small fibers damage. As with any diagnostic test, its results must be interpreted in a global context including the clinic and other examinations performed. Please read the user manual instructions carefully. Contact our office for more information. Last update: 2021/01/12
